As Advocates Celebrate a 'Renaissance,' Could Psychedelics Become the Next Cannabis?

Oregon voters legalized psilocybin mushrooms for therapy, but don't expect consumer sales anytime soon

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

When Oregon voters decided this week to legalize psychedelic drugs—the first state in the country to do so—it brought the conversation around magic mushrooms and their psychoactive brethren into the mainstream. 

With new national attention comes a logical question: Are hallucinogens queuing up to be the new cannabis?

Advocates acknowledge the short mental hop between both drug categories. But on a deeper level, they hasten to add that there are few direct parallels between the fast-growing legal cannabis industry, which added five states to the market on Tuesday, and the nascent psilocybin movement.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in